Metabolic Brain Disease Impact Factor in Neuroscience Journals

Metabolic Brain Disease in Neuroscience Journals

Journal Country: United States
Journal Q tier: Q2
Publishing Firm: Springer New York
History: 1986-2022
Journal Homepage: Not Available
Journal ISSN: 15737365, 08857490

Research Categories

Biochemistry (Q2); Neurology (clinical) (Q2); Cellular and Molecular Neuroscience (Q3)

Impact Score: 3.53
h-Index: 74
SJR: 0.761
Ranking: 6398

About Metabolic Brain Disease

Metabolic Brain Disease is a journal covering the technologies/fields/categories related to Biochemistry (Q2); Neurology (clinical) (Q2); Cellular and Molecular Neuroscience (Q3). It is published by Springer New York. The overall rank of Metabolic Brain Disease is 6398.According to SCImago Journal Rank (SJR), this journal is ranked 0.761. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come. SJR acts as an alternative to the Journal Impact Factor (or an average number of citations received in last 2 years). This journal has an h-index of 74. The best quartile for this journal is Q2.The ISSN of Metabolic Brain Disease journal is 15737365, 08857490.An International Standard Serial Number (ISSN) is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic. Metabolic Brain Disease is cited by a total of 1908 articles during the last 3 years (Preceding 2022).

Log in to add a review. Log in

No reviews yet. Be the first to review this journal.